Comparison of diagnostic performance between induced sputum or endotracheal aspiration and bronchoalveolar lavage fluid in Pneumocystis jirovecii pneumonia

Phase 3

• Conditions: AdultImmunocompromised host; PCP; immunocompromised host; Qauntitative PCR

• Registration Number: TCTR20221027003
• Lead Sponsor: /A

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-10-27
• Study Completion: 2024-04-30
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending (Not yet recruiting)
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

Inpatient
Immunocompromised host or received immunosuppressive agent
Suspected pneumonia
Performed bronchoalveolar lavage

Exclusion Criteria

Not performed bronchoalveolar lavage
Active Covid 19 infection

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Sensitivity and Specificity 18month qPCR

Secondary Outcome Measures

Name	Time	Method
agreement of diagnosis 18 month qPCR